Because we don’t hear much about TCM in the West, this blog post is about TCM herbal medicine and randomized clinical studies treating Covid-19. These are often difficult to find so I have attached the WHO documentation and studies below.

Enjoy and Be Well.  Stay healthy with Immune Boost Herb Pack here.

---

“The World Health Organization (WHO) decided to convene a meeting of experts to evaluate the role of Traditional Chinese Medicine (TCM) in the treatment of COVID-19. The subsequent Expert Meeting on Evaluation of Traditional Chinese Medicine in the Treatment of COVID-19 was held virtually from 28 February to 02 March 2022.

The objectives of the meeting were:

• to understand the methodology applied in producing the reports;
• to review and analyze the reports and randomized controlled trials of TCM in various phases of the progression of COVID-19 disease;
• to evaluate the contribution of a TCM integrated approach in the treatment of COVID-19; and
• to discuss how effectively to enhance the contribution of traditional medicine in global pandemics.

The 21 international experts from the six WHO regions included members of the WHO Expert Advisory Panel, representatives of WHO collaborating centers, members of the WHO International Regulatory Cooperation for Herbal Medicines (IRCH), and members of the China Academy of Chinese Medical Sciences. Technical staff from WHO headquarters, regional and country offices also attended the meeting.

This meeting report describes the discussion among the experts and the consensus reached reviewing three reports on traditional Chinese medicine and COVID-19 provided by national expert groups in China and 12 randomized controlled trials (RCTs) which had been registered and published as well.”   https://www.who.int/publications/m/item/who-expert-meeting-on-evaluation-of-traditional-chinese-medicine-in-the-treatment-of-covid-19

WHO-TCM expert-meeting-on-evaluation-of-tcm-in-the-treatment-of-covid-

 

Hu K, Guan W-J, Bi Y, Zhang W, Li L, Zhang B et al. Efficacy and safety of Lianhuaqingwen capsules, a
repurposed Chinese herb, in patients with coronavirus disease 2019: a multicenter, prospective, randomized
controlled trial. Phytomedicine. 2021;85:153242. doi: 10.1016/j.phymed.2020.153242.

Zhang L Zheng X, Bai X, Wang Q, Chen B, Wang H et al. Association between use of Qingfei Paidu Tang and
mortality in hospitalized patients with COVID-19: a national retrospective registry study. Phytomedicine.
2021;85:153531. doi: 10.1016/j.phymed.2021.153531.

Chen Y, Liu C, Wang T, Qi J, Jia X, Zeng X et al. Efficacy and safety of Bufei Huoxue capsules in the
management of convalescent patients with COVID-19 infection: a multicentre, double-blind, and randomised
controlled trial. J Ethnopharmacol, 2022;284:114830. doi: 10.1016/j.jep.2021.114830.

 

Shi N, Liu B, Liang N, Ma Y, Ge Y, Yi H et al. Association between early treatment with Qingfei Paidu decoction
and favorable clinical outcomes in patients with COVID-19: a retrospective multicenter cohort study.
Pharmacol Res. 2020;161:105290. doi: 10.1016/j.phrs.2020.105290.

Zhao C, Li L, Yang W, Lv W, Wang J, Guo J et al. Chinese medicine formula Huashibaidu granule early
treatment for mild COVID-19 patients: an unblinded, cluster-randomized clinical trial. Front Med. 2021;16
Sept. doi.org/10.3389/fmed.2021.696976.

Hu K, Guan WJ, Bi Y, Zhang W, Li L, Zhang B et al. Efficacy and safety of Lianhuaqingwen capsules, a
repurposed Chinese herb, in patients with coronavirus disease 2019: a multicenter, prospective, randomized
controlled trial. Phytomedicine. 2021;85:153242. doi:10.1016/j.phymed.2020.153242.

Luo Z, Chen W, Xiang M, Wang H, Xiao W, Xu C et al. The preventive effect of Xuebijing injection against
cytokine storm for severe patients with COVID-19: a prospective randomized controlled trial. Eur J Integr Med.
2021;42:101305. doi: 10.1016/j.eujim.2021.101305.